Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Santaolalla, Aida"'
Autor:
Beckmann, Kerri, Santaolalla, Aida, Sugimoto, Mikio, Carroll, Peter, Rubio, Jose, Villers, Arnauld, Bjartell, Anders, Morgan, Todd, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
Publikováno v:
Prostate cancer and prostatic diseases, vol 26, iss 2
BackgroundCurrently, follow-up protocols are applied equally to men on active surveillance (AS) for prostate cancer (PCa) regardless of findings at their initial follow-up biopsy. To determine whether less intensive follow-up is suitable following ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9c99680c86f1ed8249c4298ddae8a8e3
https://escholarship.org/uc/item/5dk12186
https://escholarship.org/uc/item/5dk12186
Autor:
Santaolalla, Aida, Garmo, Hans, Grigoriadis, Anita, Ghuman, Sundeep, Hammar, Niklas, Jungner, Ingmar, Walldius, Göran, Lambe, Mats, Holmberg, Lars, Van Hemelrijck, Mieke
Publikováno v:
BMC Molecular and Cell Biology
Santa Olalla, A, Van Hemelrijck, M, Holmberg, L H, Grigoriadis, A, Ghuman, S, Hammar, N, Lambe, M, Garmo, H G, Walldius, G & Jungner, I 2019, ' Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis ', BMC Molecular Biology, vol. 20, no. 1, 28 . https://doi.org/10.1186/s12860-019-0210-7
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-15 (2019)
Santa Olalla, A, Van Hemelrijck, M, Holmberg, L H, Grigoriadis, A, Ghuman, S, Hammar, N, Lambe, M, Garmo, H G, Walldius, G & Jungner, I 2019, ' Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis ', BMC Molecular Biology, vol. 20, no. 1, 28 . https://doi.org/10.1186/s12860-019-0210-7
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-15 (2019)
Background Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and impro
Autor:
Bruinsma, Sophie M., Zhang, Liying, Roobol, Monique J., Bangma, Chris H., Steyerberg, Ewout W., Nieboer, Daan, Van Hemelrijck, Mieke, Trock, Bruce, Ehdaie, Behfar, Carroll, Peter, Filson, Christopher, Kim, Jeri, Morgan, Todd, Klotz, Laurence, Pickles, Tom, Hyndman, Eric, Moore, Caroline M., Gnanapragasam, Vincent, Dasgupta, Prokar, Villers, Arnauld, Rannikko, Antti, Valdagni, Riccardo, Perry, Antoinette, Hugosson, Jonas, Rubio-Briones, Jose, Bjartell, Anders, Hefermehl, Lukas, Lui Shiong, Lee, Frydenberg, Mark, Kakehi, Yoshiyuki, Ha Chung, Byung, van der Kwast, Theo, Obbink, Henk, van der Linden, Wim, Hulsen, Tim, de Jonge, Cees, Kattan, Mike, Xinge, Ji, Muir, Kenneth, Lophatananon, Artitaya, Fahey, Michael, Guo, Wei, Milan, Tanya, Benfante, Nicole, Cowan, Janet, Patil, Dattatraya, Sanford, Rachel, Kim, Tae Kyung, Mamedov, Alexandre, Santaolalla, Aida
Publikováno v:
BJU International, 121(5), 737-744. Wiley-Blackwell Publishing Ltd
Bruinsma, S M, Zhang, L, Roobol, M J, Bangma, C H, Steyerberg, E W, Nieboer, D, Van Hemelrijck, M, Trock, B, Ehdaie, B, Carroll, P, Filson, C, Kim, J, Morgan, T, Klotz, L, Pickles, T, Hyndman, E, Moore, C M, Gnanapragasam, V, Dasgupta, P, Villers, A, Rannikko, A, Valdagni, R, Perry, A, Hugosson, J, Rubio-Briones, J, Bjartell, A, Hefermehl, L, Lui Shiong, L, Frydenberg, M, Kakehi, Y, Ha Chung, B, van der Kwast, T, Obbink, H, van der Linden, W, Hulsen, T, de Jonge, C, Kattan, M, Xinge, J, Muir, K, Lophatananon, A, Fahey, M, Guo, W, Milan, T, Benfante, N, Cowan, J, Patil, D, Sanford, R, Kim, T K & Mamedov, A & Santaolalla, A 2018, ' The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date ', BJU International, vol. 121, no. 5, pp. 737-744 . https://doi.org/10.1111/bju.14106
Bruinsma, S M, Zhang, L, Roobol, M J, Bangma, C H, Steyerberg, E W, Nieboer, D, Van Hemelrijck, M, Trock, B, Ehdaie, B, Carroll, P, Filson, C, Kim, J, Morgan, T, Klotz, L, Pickles, T, Hyndman, E, Moore, C M, Gnanapragasam, V, Dasgupta, P, Villers, A, Rannikko, A, Valdagni, R, Perry, A, Hugosson, J, Rubio-Briones, J, Bjartell, A, Hefermehl, L, Lui Shiong, L, Frydenberg, M, Kakehi, Y, Ha Chung, B, van der Kwast, T, Obbink, H, van der Linden, W, Hulsen, T, de Jonge, C, Kattan, M, Xinge, J, Muir, K, Lophatananon, A, Fahey, M, Guo, W, Milan, T, Benfante, N, Cowan, J, Patil, D, Sanford, R, Kim, T K & Mamedov, A & Santaolalla, A 2018, ' The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date ', BJU International, vol. 121, no. 5, pp. 737-744 . https://doi.org/10.1111/bju.14106
Objectives: The Movember Foundation launched the Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative to create a global consensus on the selection and monitoring of men with low-risk prostate cancer (PCa) on active surveillance (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0125e3b21d61bac090b1a64824d825b
https://pure.eur.nl/en/publications/a5a1ac36-c3a7-4c25-92cf-ce035e3f0856
https://pure.eur.nl/en/publications/a5a1ac36-c3a7-4c25-92cf-ce035e3f0856
Autor:
Kerri R, Beckmann, Chris H, Bangma, Jozien, Helleman, Anders, Bjartell, Peter R, Carroll, Todd, Morgan, Daan, Nieboer, Aida, Santaolalla, Bruce J, Trock, Riccardo, Valdagni, Monique J, Roobol
Publikováno v:
Prostate, 82(7), 876-879. Wiley-Liss Inc.
2022, ' Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer : An analysis of the G.A.P.3 global consortium database ', Prostate, vol. 82, no. 7, pp. 876-879 . https://doi.org/10.1002/pros.24330
2022, ' Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer : An analysis of the G.A.P.3 global consortium database ', Prostate, vol. 82, no. 7, pp. 876-879 . https://doi.org/10.1002/pros.24330
Refereed/Peer-reviewed Background: The optimal interval for repeat biopsy during active surveillance (AS) for prostate cancer is yet to be defined. This study examined whether risk of upgrading (to grade group ≥ 2) or risk of converting to treatmen
Autor:
Maria J Monroy-Iglesias, Silvia Crescioli, Kerri Beckmann, Nga Le, Sophia N Karagiannis, Mieke Van Hemelrijck, Aida Santaolalla
Publikováno v:
Clinical and Experimental Immunology. 209:46-63
Increasing evidence has linked the humoral immune response with the development of various cancers. Therefore, there is growing interest in investigating the predictive value of antibodies to assess overall and tissue site-specific cancer risk. Given
Autor:
Kerri Beckmann, Benjamin Challacombe, Sharon Clovis, Oussama Elhage, Christian Brown, Prokar Dasgupta, Aida Santaolalla, Rick Popert, Preeti Sandhu, Paul Cathcart, Mieke Van Hemelrijck, Sohail Singh, Grace Zisengwe, Kamal Dewan, Jonah Rusere
To determine the risk of disease progression and conversion to active treatment following a negative biopsy while on active surveillance (AS) for prostate cancer (PCa).Men on an AS programme at a single tertiary hospital (London, UK) between 2003 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb7104cd7401c6841dc2ed705b22fb5
https://hdl.handle.net/11541.2/144947
https://hdl.handle.net/11541.2/144947
Autor:
Rick Popert, Kerri Beckmann, Jonah Rusere, Grace Zisengwe, Aida Santaolalla, Salonee Shah, Oussama Elhage, Mieke Van Hemelrijck, Prokar Dasgupta, Ben Challacombe
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Background The routine clinical use of serum prostatic specific antigen (PSA) testing has allowed earlier detection of low-grade prostate cancer (PCa) with more favourable characteristics, leading to increased acceptance of management by active surve